Strategic Investment Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$812K Buy
+13,808
New +$1.1M 0.06% 166
2025
Q3
Sell
-8,860
Closed -$945K 268
2025
Q2
$945K Sell
8,860
-2,676
-23% -$271K 0.09% 104
2025
Q1
$1.16M Sell
11,536
-806
-7% -$81.2K 0.12% 92
2024
Q4
$1.1M Sell
12,342
-1,011
-8% -$89K 0.12% 102
2024
Q3
$1.12M Sell
13,353
-548
-4% -$43.2K 0.12% 106
2024
Q2
$1.07M Buy
13,901
+1,705
+14% +$125K 0.13% 100
2024
Q1
$835K Sell
12,196
-812
-6% -$52.2K 0.11% 122
2023
Q4
$752K Sell
13,008
-811
-6% -$43.3K 0.11% 125
2023
Q3
$730K Buy
13,819
+4,170
+43% +$219K 0.12% 126
2023
Q2
$522K Sell
9,649
-266
-3% -$13.9K 0.07% 135
2023
Q1
$496K Buy
+9,915
New +$467K 0.09% 161

Other funds holding BSX

Strategic Investment Advisors's BSX Position: Q1 2026 in Review

Strategic Investment Advisors opened a new position in Boston Scientific (BSX) in Q1 2026: 13,808 shares worth $812K. The stake represents 0.06% of the portfolio and ranks #166 among its holdings. This is a return to the name: Strategic Investment Advisors previously reported a position in BSX as recently as Q2 2025.

Strategic Investment Advisors first reported a position in BSX in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.16M in Q1 2025. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Strategic Investment Advisors held 13,808 shares of Boston Scientific worth $812K as of Q1 2026.
  • Boston Scientific was a new Strategic Investment Advisors position in Q1 2026.
  • Boston Scientific made up 0.06% of Strategic Investment Advisors's portfolio in Q1 2026, its #166 holding.
  • Strategic Investment Advisors first reported a position in Boston Scientific in Q1 2023 and has held it in 11 quarters since.
  • Strategic Investment Advisors's Boston Scientific position peaked at $1.16M in Q1 2025.
  • 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Strategic Investment Advisors's 13F filing for Q1 2026, filed 18 May 2026.